UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Post-Discharge Treatment Patterns among Patients Treated with Apixaban or Warfarin during Hospitalization for Venous Thromboembolism (VTE)

Journal of clinical medicine, 2024-06, Vol.13 (12), p.3512

2024

Volltextzugriff (PDF)

Patterns of use of systemic therapies among patients with metastatic melanoma: a retrospective claims database analysis in the United States

The Journal of dermatological treatment, 2017-08, Vol.28 (6), p.549-553

2017

Volltextzugriff (PDF)

Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer

Thrombosis research, 2023-06, Vol.226, p.117-126

2023

Volltextzugriff (PDF)

Payer formulary exclusions of apixaban: how patients respond and potential implications

Current medical research and opinion, 2022-11, Vol.38 (11), p.1885-1890

2022

Volltextzugriff (PDF)

Evaluation of Resource Utilization and Treatment Patterns in Patients with Actinic Keratosis in the United States

Value in health, 2016-03, Vol.19 (2), p.239-248

2016

Volltextzugriff (PDF)

Erenumab patient characteristics, medication adherence, and treatment patterns in the United States

Headache, 2021-04, Vol.61 (4), p.590-602

2021

Volltextzugriff (PDF)

Payer formulary tier increases of apixaban: how patients respond and potential implications

Current medical research and opinion, 2023-08, Vol.39 (8), p.1-1101

2023

Volltextzugriff (PDF)

Risk of stroke/systemic embolism, major bleeding, and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States medicare population: updated analysis

Current medical research and opinion, 2022-12, Vol.38 (12), p.2131-2140

2022

Volltextzugriff (PDF)

Journey to Anticoagulant Access Following Payer Rejection of Apixaban

The American journal of managed care, 2023-11, Vol.29 (11), p.e330-e338

Deitelzweig, Steven

2023

Volltextzugriff (PDF)

Payer approval and rejection of oral anticoagulant prescriptions and prescription abandonment patterns among patients with venous thromboembolism

Journal of managed care & specialty pharmacy, 2024-05, Vol.30 (5), p.441-455

2024

Volltextzugriff (PDF)

Effectiveness and safety of anticoagulants among patients with venous thromboembolism and common cancers or cancers with high venous thromboembolism risk

Future oncology (London, England), 2024-03, Vol.20 (9), p.521-532

2024

Volltextzugriff (PDF)

Effectiveness and safety of anticoagulants among patients with venous thromboembolism and active cancer who also had prior bleed or prior renal disease

Current medical research and opinion, 2024-03, Vol.40 (3), p.545-553

2024

Volltextzugriff (PDF)

Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences

Advances in therapy, 2023-04, Vol.40 (4), p.1705-1735

2023

Volltextzugriff (PDF)

A Real-World Evaluation of Primary Medication Nonadherence in Patients with Nonvalvular Atrial Fibrillation Prescribed Oral Anticoagulants in the United States

American journal of cardiovascular drugs : drugs, devices, and other interventions, 2023-09, Vol.23 (5), p.559-572

2023

Volltextzugriff (PDF)

Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database

Journal of medical economics, 2018-06, Vol.21 (6), p.622-628

2018

Volltextzugriff (PDF)

Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors

Vascular health and risk management, 2018-01, Vol.14, p.409-418

2018

Volltextzugriff (PDF)

Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment

Patient preference and adherence, 2019-01, Vol.13, p.1927-1939

2019

Volltextzugriff (PDF)

Real-world evidence for carfilzomib dosing intensity on overall survival and treatment progression in multiple myeloma patients

Journal of oncology pharmacy practice, 2022-07, Vol.28 (5), p.1130-1139

2022

Volltextzugriff (PDF)

Estimation of the Incremental Cumulative Cost of HIV Compared with a Non-HIV Population

PharmacoEconomics - open, 2020-12, Vol.4 (4), p.687-696

2020

Volltextzugriff (PDF)

Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset

Dermatology and therapy, 2022-06, Vol.12 (6), p.1337-1350

2022

Volltextzugriff (PDF)

Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis

Advances in therapy, 2016-07, Vol.33 (7), p.1180-1198

2016

Volltextzugriff (PDF)

The Race Study: Comparison of Carrying Time, Confidence in Epinephrine Auto-Injector (EAI) Use, and Experience with EAI Training Among Patients with Auvi-Q Versus Epipen

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB209-AB209

2015

Volltextzugriff (PDF)

The Race Study: Confidence and Training Experience with Epinephrine Auto-Injectors (EAIs) Among Patients at Risk of Anaphylaxis

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB209-AB209

2015

Volltextzugriff (PDF)

The Race Study: Predictors of Carrying Epinephrine Auto-Injector Devices (EAIs)

Journal of allergy and clinical immunology, 2015-02, Vol.135 (2), p.AB210-AB210

2015

Volltextzugriff (PDF)

Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients

Therapeutics and clinical risk management, 2018-01, Vol.14, p.2425-2435

2018

Volltextzugriff (PDF)

1 – 25 von 37

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(36)
Berichte
(1)

Sprache

Englisch
(37)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Post-Discharge Treatment Patterns among Patients Treated with Apixaban or Warfarin during Hospitalization for Venous Thromboembolism (VTE)

Patterns of use of systemic therapies among patients with metastatic melanoma: a retrospective claims database analysis in the United States

Effectiveness and safety of anticoagulants among venous thromboembolism cancer patients with and without brain cancer

Payer formulary exclusions of apixaban: how patients respond and potential implications

Evaluation of Resource Utilization and Treatment Patterns in Patients with Actinic Keratosis in the United States

Erenumab patient characteristics, medication adherence, and treatment patterns in the United States

Payer formulary tier increases of apixaban: how patients respond and potential implications

Risk of stroke/systemic embolism, major bleeding, and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States medicare population: updated analysis

Journey to Anticoagulant Access Following Payer Rejection of Apixaban

Payer approval and rejection of oral anticoagulant prescriptions and prescription abandonment patterns among patients with venous thromboembolism

Effectiveness and safety of anticoagulants among patients with venous thromboembolism and common cancers or cancers with high venous thromboembolism risk

Effectiveness and safety of anticoagulants among patients with venous thromboembolism and active cancer who also had prior bleed or prior renal disease

Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences

A Real-World Evaluation of Primary Medication Nonadherence in Patients with Nonvalvular Atrial Fibrillation Prescribed Oral Anticoagulants in the United States

Economic burden of skeletal-related events in patients with multiple myeloma: analysis of US commercial claims database

Treatment patterns and patient characteristics among early initiators of PCSK9 inhibitors

Treatment Adherence And Persistence Among HIV-1 Patients Newly Starting Treatment

Real-world evidence for carfilzomib dosing intensity on overall survival and treatment progression in multiple myeloma patients

Estimation of the Incremental Cumulative Cost of HIV Compared with a Non-HIV Population

Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset

Comorbidity Burden in Trial-Aligned Patients with Established Gout in Germany, UK, US, and France: a Retrospective Analysis

The Race Study: Comparison of Carrying Time, Confidence in Epinephrine Auto-Injector (EAI) Use, and Experience with EAI Training Among Patients with Auvi-Q Versus Epipen

The Race Study: Confidence and Training Experience with Epinephrine Auto-Injectors (EAIs) Among Patients at Risk of Anaphylaxis

The Race Study: Predictors of Carrying Epinephrine Auto-Injector Devices (EAIs)

Low-density lipoprotein cholesterol outcomes post-non-PCSK9i lipid-lowering therapies in atherosclerotic cardiovascular disease and probable heterozygous familial hypercholesterolemia patients

Suchergebnisse filtern